DrugMapper
  • Browse
    • Therapeutic Area
      • CANCER (51)
      • CARDIOVASCULAR (45)
      • DENTISTRY (2)
      • DERMATOLOGY (31)
      • DIABETES DRUGS & ENDOCRINOLOGY (61)
      • EMERGENCY MEDICINE (3)
      • ENT (5)
      • EYE (23)
      • GASTROINTESTINAL (29)
      • HEMATOLOGY (23)
      • MUSCULOSKELETAL (28)
      • NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
      • PEDIATRICS (27)
      • PHARMACOLOGY (8)
      • PREGNANCY AND GYNECOLOGY (30)
      • RESPIRATORY (42)
      • RHEUMATOLOGY (19)
      • OTHER (1482)
    • Therapeutic Indication
    • Adverse Reaction (System Organ Classification)
    • Mechanism of Action
    • Primary Target
    • Target Level
      • Level 1
      • Level 2
      • Level 3
      • Level 4
      • Level 5
      • Level 6
    • Active Pharmaceutical Ingredients (APIs)
    • Small Molecules
    • ProDrugs
    • Antibodies
    • CNS drugs
    • Metabolites
  • Search
      Therapeutic Indication Adverse Reaction (System Organ Classification)
      Mechanism of Action Target Sequence
      Chemical Structure Physicochemical Properties
  • Analyze

      Networks

    • Chemical Similarity
    • Scaffold Similarity
    • KNIME workflow
  • Downloads
      Web services Bulk Downloads
  • About
      DrugMapper FAQs Data Sources Contact Us

INVAC-1, A DOUBLE STRANDED DNA PLASMID VACCINE CONSTRUCT ENCODING UBIQUITIN-HUMAN TELOMERASE REVERSE TRANSCRIPTASE (HTERT) FUSION PROTEIN

Search structure
Synonyms:
Invac-1
INVAC-1
Invac-1, a double stranded dna plasmid vaccine construct encoding ubiquitin-human telomerase reverse transcriptase (htert) fusion protein
Status: Phase 2
Entry Type: Enzyme
Molecule Category: UNKNOWN
UNII: S8GQZ8LF0D

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Leukemia, Lymphocytic, Chronic, B-Cell 2 D015451 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4594561
FDA SRS S8GQZ8LF0D
CONTENTS
  • Structure
  • Indications
  • Cross References
×
70